Showing results (381-390 of 431) with videos related to
Sort By:
Pageof 44
Endocrine Pathology|September 23, 2020
Immunohistochemistry or Molecular Analysis: Which Method Is Better for Subtyping Craniopharyngioma?Noriaki Fukuhara, Takeo Iwata, Naoko Inoshita, et al.Bio-Protocol|September 20, 2021
Optimised Method for the Production and Titration of Lentiviral Vectors Pseudotyped with the SARS-CoV-2 SpikeLeila Mekkaoui, Emma M Bentley, Mathieu Ferrari, et al.Communications Medicine|March 14, 2025
Age- and vaccination status-dependent isolation guidelines based on simulation of SARS-CoV-2 Delta cases in SingaporeKeisuke Ejima, Marco Ajelli, Ananya Singh, et al.Journal of Medical Virology|February 2, 2026
Comparing Cross-Sectional and Longitudinal Study Designs for Accurate Viral Dynamics Estimation: Insights From the NBA Cohort DataJihyeon Kim, Hyeongki Park, Hoong Kai Chua, et al.Vaccines|November 25, 2023
Antibody Profiling of Microbial Antigens in the Blood of COVID-19 mRNA Vaccine Recipients Using Microbial Protein MicroarraysHiroaki Saito, Hiroki Yoshimura, Makoto Yoshida, et al.American Journal of Industrial Medicine|December 24, 2003
A survey on exposure level, health status, and biomarkers in workers exposed to 1-bromopropaneGaku Ichihara, Weihua Li, Xuncheng Ding, et al.Journal of Bone and Mineral Metabolism|July 13, 2021
Clinical performance of a novel chemiluminescent enzyme immunoassay for FGF23Nobuaki Ito, Takuo Kubota, Sachiko Kitanaka, et al.Toxicological Sciences : an Official Journal of the Society of Toxicology|April 19, 2002
Biochemical changes in the central nervous system of rats exposed to 1-bromopropane for seven daysHailan Wang, Gaku Ichihara, Hidenori Ito, et al.Plos Medicine|July 6, 2021
Detection of significant antiviral drug effects on COVID-19 with reasonable sample sizes in randomized controlled trials: A modeling studyShoya Iwanami, Keisuke Ejima, Kwang Su Kim, et al.Trials|April 29, 2021
Efficacy and safety of nelfinavir in asymptomatic and mild COVID-19 patients: a structured summary of a study protocol for a multicenter, randomized controlled trialNaoki Hosogaya, Taiga Miyazaki, Yuri Fukushige, et al.Pageof 44